<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Constitutional molecular defects are known to play a role in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e>, as shown by the increased incidence of embryonic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in children with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) or of <z:hpo ids='HP_0001909'>leukemia</z:hpo> in children with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To establish the incidence and spectrum of malformation syndromes associated with <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancer</z:e> we performed a clinical morphological examination on a series of 1,073 children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We diagnosed a syndrome in 42 patients (3.9%) and suspected the presence of a syndrome in another 35 patients (3.3%), for a total of 7.2% </plain></SENT>
<SENT sid="3" pm="."><plain>This incidence of patients with a proven or suspected syndrome is high, and points to a possible association </plain></SENT>
<SENT sid="4" pm="."><plain>We describe new syndrome-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> associations in several entities: <z:e sem="disease" ids="C0008928" disease_type="Disease or Syndrome" abbrv="CLCD">cleidocranial dysostosis</z:e> (<z:hpo ids='HP_0002667'>Wilms tumor</z:hpo>), <z:e sem="disease" ids="C0752166" disease_type="Disease or Syndrome" abbrv="">Bardet-Biedl syndrome (BBS)</z:e> (<z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>), <z:e sem="disease" ids="C0796004" disease_type="Disease or Syndrome" abbrv="">Kabuki syndrome</z:e> (<z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>), <z:e sem="disease" ids="C0175704" disease_type="Disease or Syndrome" abbrv="">LEOPARD syndrome</z:e> (<z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>), <z:e sem="disease" ids="C0032357" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Poland anomaly</z:e> (<z:hpo ids='HP_0002669'>osteosarcoma</z:hpo>; <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin disease</z:e>), and <z:hpo ids='HP_0000581'>blepharophimosis</z:hpo> <z:hpo ids='HP_0000537'>epicanthus inversus</z:hpo> syndrome (Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty of the 42 syndrome diagnoses were not recognized in the patients prior to this study, indicating that these diagnoses are commonly missed </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that <z:hpo ids='HP_0000001'>all</z:hpo> children with a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> should be examined by a clinical geneticist or a pediatrician skilled in clinical <z:mp ids='MP_0000002'>morphology</z:mp> to determine if the patients have a malformation syndrome </plain></SENT>
</text></document>